EcoR1 Capital Fund L.P. 13D/13G Filings for Ovid Therapeutics Inc. (OVID)

EcoR1 Capital Fund L.P. 13D and 13G filings for Ovid Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-03-09
2:31 pm
Unchanged		 2021-03-04 13G Ovid Therapeutics Inc.
OVID		 EcoR1 Capital Fund L.P. 6,082,200
9.600%		 0
(Unchanged)		 Filing
2021-03-09
1:19 pm
Purchase		 2020-03-04 13G Ovid Therapeutics Inc.
OVID		 EcoR1 Capital Fund L.P. 6,082,200
9.600%		 6,082,200increase
(New Position)		 Filing